Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Abroad (travel likely)Recruiting

Conditions

Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CSMC, Los Angeles, California, United States
Contact: Study coordinator (Enrique Vargas, MD) · enrique.vargas@cshs.org · 972-281-7187

Study leads

Golnaz Yadollahikhales, MD
Principal Investigator
Cedars Siinai Medical Center Department of Neurology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease

AD · Early Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Chongqing, China

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1

Montreal, Canada · Amsterdam, Netherlands

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Mild Cognitive Impairment · Alzheimer Disease · Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE1

San Diego, United States

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders

Alzheimer's Disease · Frontotemporal Degeneration (Semantic & Behavioral Variants)

Abroad (travel likely)Recruiting

Lille, France